James F. Pingpank

6.3k total citations
103 papers, 3.8k citations indexed

About

James F. Pingpank is a scholar working on Surgery, Oncology and Emergency Medicine. According to data from OpenAlex, James F. Pingpank has authored 103 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Surgery, 45 papers in Oncology and 28 papers in Emergency Medicine. Recurrent topics in James F. Pingpank's work include Intraperitoneal and Appendiceal Malignancies (40 papers), Appendicitis Diagnosis and Management (28 papers) and Hepatocellular Carcinoma Treatment and Prognosis (18 papers). James F. Pingpank is often cited by papers focused on Intraperitoneal and Appendiceal Malignancies (40 papers), Appendicitis Diagnosis and Management (28 papers) and Hepatocellular Carcinoma Treatment and Prognosis (18 papers). James F. Pingpank collaborates with scholars based in United States, India and Malaysia. James F. Pingpank's co-authors include H. Richard Alexander, Steven K. Libutti, David L. Bartlett, Aaron R. Sasson, Seth M. Steinberg, Herbert J. Zeh, Matthew P. Holtzman, Haroon A. Choudry, John P. Hoffman and Burton Eisenberg and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

James F. Pingpank

103 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James F. Pingpank United States 35 1.9k 1.5k 957 653 606 103 3.8k
Katherine M. Krajewski United States 37 1.2k 0.6× 1.6k 1.1× 1.9k 2.0× 487 0.7× 66 0.1× 134 4.4k
P Lasser France 51 4.8k 2.5× 3.9k 2.5× 2.9k 3.0× 1.7k 2.7× 714 1.2× 165 8.7k
Cynthia E. Herzog United States 32 625 0.3× 1.0k 0.7× 1.1k 1.2× 252 0.4× 61 0.1× 91 2.7k
Michaël Soussan France 31 583 0.3× 677 0.4× 1.6k 1.6× 284 0.4× 75 0.1× 98 4.0k
Karolina Sikorska Netherlands 26 1.3k 0.7× 841 0.6× 739 0.8× 216 0.3× 416 0.7× 105 2.6k
Lucas Sidéris Canada 33 2.6k 1.4× 1.3k 0.8× 413 0.4× 466 0.7× 1.1k 1.7× 118 4.0k
Priya Bhosale United States 37 1.9k 1.0× 2.5k 1.7× 1.5k 1.6× 1.2k 1.8× 56 0.1× 281 5.3k
Andrea Hayes‐Jordan United States 33 1.5k 0.8× 1.2k 0.8× 2.0k 2.1× 182 0.3× 165 0.3× 123 3.8k
Francesco Bertagna Italy 33 962 0.5× 695 0.5× 1.1k 1.1× 422 0.6× 99 0.2× 295 3.8k
R. D. T. Jenkin Canada 32 702 0.4× 898 0.6× 1.3k 1.3× 547 0.8× 47 0.1× 57 4.2k

Countries citing papers authored by James F. Pingpank

Since Specialization
Citations

This map shows the geographic impact of James F. Pingpank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James F. Pingpank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James F. Pingpank more than expected).

Fields of papers citing papers by James F. Pingpank

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James F. Pingpank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James F. Pingpank. The network helps show where James F. Pingpank may publish in the future.

Co-authorship network of co-authors of James F. Pingpank

This figure shows the co-authorship network connecting the top 25 collaborators of James F. Pingpank. A scholar is included among the top collaborators of James F. Pingpank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James F. Pingpank. James F. Pingpank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Copeland, Amy R., Sara P. Myers, Matthew P. Holtzman, et al.. (2025). Patient Perspectives of Fertility Following Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy: An Opportunity for Improved Perioperative Counseling. Journal of Surgical Research. 306. 122–128. 1 indexed citations
2.
Amatore, F., Shaum Sridharan, Arivarasan Karunamurthy, et al.. (2024). Pathologic response rates to neoadjuvant pembrolizumab in locally advanced (LA) resectable cutaneous squamous cell carcinoma (cSCC).. Journal of Clinical Oncology. 42(16_suppl). 9591–9591. 5 indexed citations
3.
Wach, Michael M., Geoffrey R. Nunns, A. Hamed, et al.. (2024). Normal CEA Levels After Neoadjuvant Chemotherapy and Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from Colorectal Peritoneal Metastases. Annals of Surgical Oncology. 31(4). 2391–2400. 4 indexed citations
4.
Wach, Michael M., Jurgis Alvikas, Michelle Zhang, et al.. (2023). Combined hepatic resection and ablation for high burden of colorectal liver metastases demonstrates safety and durable survival. HPB. 26(3). 362–369. 3 indexed citations
5.
LaFramboise, William A., Reetesh K. Pai, Patti Petrosko, et al.. (2019). Discrimination of low- and high-grade appendiceal mucinous neoplasms by targeted sequencing of cancer-related variants. Modern Pathology. 32(8). 1197–1209. 16 indexed citations
6.
Boone, Brian A., et al.. (2018). Hepatic artery infusion of melphalan in patients with liver metastases from ocular melanoma. Journal of Surgical Oncology. 117(5). 940–946. 10 indexed citations
7.
Dhir, Mashaal, Mazen S. Zenati, Heather Jones, et al.. (2017). Effectiveness of Hepatic Artery Infusion (HAI) Versus Selective Internal Radiation Therapy (Y90) for Pretreated Isolated Unresectable Colorectal Liver Metastases (IU-CRCLM). Annals of Surgical Oncology. 25(2). 550–557. 14 indexed citations
9.
Zeh, Herbert J., Howard Edington, James F. Pingpank, et al.. (2016). Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancer. Journal for ImmunoTherapy of Cancer. 4(1). 24–24. 20 indexed citations
10.
Hughes, Marybeth S., Jonathan S. Zager, Mark B. Faries, et al.. (2015). Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases. Annals of Surgical Oncology. 23(4). 1309–1319. 101 indexed citations
11.
Davison, Jon M., Haroon A. Choudry, James F. Pingpank, et al.. (2014). Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade. Modern Pathology. 27(11). 1521–1539. 124 indexed citations
12.
Magge, Deepa, Amer H. Zureikat, David L. Bartlett, et al.. (2013). A Phase I Trial of Isolated Hepatic Perfusion (IHP) Using 5-FU and Oxaliplatin in Patients with Unresectable Isolated Liver Metastases from Colorectal Cancer. Annals of Surgical Oncology. 20(7). 2180–2187. 6 indexed citations
13.
Alexander, H. Richard, David L. Bartlett, James F. Pingpank, et al.. (2013). Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma. Surgery. 153(6). 779–786. 105 indexed citations
14.
Wagner, Patrick, Frances Austin, Ugwuji N. Maduekwe, et al.. (2013). Extensive Cytoreductive Surgery for Appendiceal Carcinomatosis: Morbidity, Mortality, and Survival. Annals of Surgical Oncology. 20(4). 1056–1062. 28 indexed citations
15.
Magge, Deepa, Amer H. Zureikat, David L. Bartlett, et al.. (2012). A phase I trial of isolated hepatic perfusion (IHP) using 5-FU and oxaliplatin in patients with unresectable isolated liver metastases (ILM) from colorectal cancer (CRC).. Journal of Clinical Oncology. 30(4_suppl). 283–283. 1 indexed citations
16.
Miao, Ning, James F. Pingpank, H. Richard Alexander, et al.. (2008). Percutaneous Hepatic Perfusion in Patients with Metastatic Liver Cancer: Anesthetic, Hemodynamic, and Metabolic Considerations. Annals of Surgical Oncology. 15(3). 815–823. 34 indexed citations
17.
Powell, Anathea C., Constantine A. Stratakis, Nicholas J. Patronas, et al.. (2008). Operative management of Cushing Syndrome secondary to micronodular adrenal hyperplasia. Surgery. 143(6). 750–758. 48 indexed citations
18.
Pingpank, James F., et al.. (2007). Malignant insulinoma: a rare presentation of a rare tumor. Gastrointestinal Endoscopy. 66(6). 1228–1229. 2 indexed citations
19.
Grover, Amelia, Monica C. Skarulis, H. Richard Alexander, et al.. (2005). A prospective evaluation of laparoscopic exploration with intraoperative ultrasound as a technique for localizing sporadic insulinomas. Surgery. 138(6). 1003–1008. 47 indexed citations
20.
Farma, Jeffrey M., James F. Pingpank, Steven K. Libutti, et al.. (2005). Limited Survival in Patients With Carcinomatosis From Foregut Malignancies After Cytoreduction and Continuous Hyperthermic Peritoneal Perfusion. Journal of Gastrointestinal Surgery. 9(9). 1346–1353. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026